16 results
10-Q
2023 Q3
EX-3.1
TRML
Tourmaline Bio Inc
Quarterly report
14 Nov 23
5:12pm
8-K
EX-3.1
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-3.2
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-3.3
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
S-4
EX-3.1
TRML
Tourmaline Bio Inc
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-3.2
5vjcl h0rz
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-3.3
y8fsc6qbyyg3
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
8-K
EX-3.1
sbywj4tnr4y052rto98
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
8-K
EX-3.2
jven3o
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
S-1/A
EX-3.2
gjudhvjwqd328lf0
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.1
z8quzt 3l3fx1h
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.4
cubbggwklo4r90
3 May 21
IPO registration (amended)
6:07am
S-1
EX-3.3
qnxxtcp c059dlmvp
16 Apr 21
IPO registration
5:03pm
S-1
EX-3.1
895nw1u rx2yqkxzk
16 Apr 21
IPO registration
5:03pm
DRS
EX-3.1
zdr4knvmznpj
26 Feb 21
Draft registration statement
12:00am
DRS
EX-3.3
c1rqpresm gznom
26 Feb 21
Draft registration statement
12:00am
- Prev
- 1
- Next